Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noreen Griffin

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Gastroenterology & Hepatology|October 1, 2011
The cantankerous pancreasR Thomas Temes, Noreen Griffin
International Immunopharmacology|June 10, 2018
Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapyZijian Li, Yue You, Noreen Griffin, et al.
International Immunopharmacology|March 2, 2016
Methionine enkephalin, its role in immunoregulation and cancer therapyDingliang Zhao, Nicolas Plotnikoff, Noreen Griffin, et al.
International Immunopharmacology|July 27, 2021
A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironmentShuling Zhang, Hai Huang, Mike Handley, et al.
International Immunopharmacology|January 24, 2014
Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs)Jingjuan Meng, Yiming Meng, Nicholas P Plotnikoff, et al.
International Immunopharmacology|December 14, 2019
Methionine enkephalin inhibits influenza A virus infection through upregulating antiviral state in RAW264.7 cellsJing Tian, Na Qu, Xue Jiao, et al.
International Immunopharmacology|September 23, 2023
Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b<sup>+</sup> NCR1<sup>+</sup> NKs of tumor microenvironmentNa Qu, Yiming Meng, Jingbo Zhai, et al.
International Immunopharmacology|August 27, 2016
Functional modulation on macrophage by low dose naltrexone (LDN)Zhe Yi, Shengnan Guo, Xu Hu, et al.
International Immunopharmacology|November 17, 2023
In vitro and in vivo killing effects of methionine enkephalin on osteosarcomaHai Huang, Xiaonan Wang, Shuling Zhang, et al.
International Immunopharmacology|July 28, 2024
Corrigendum to "Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b+ NCR1+ NKs of tumor microenvironment" [Int. Immunopharmacol. 124(Pt B) (2023) 110967. doi: 10.1016/j.intimp.2023.110967. Epub 2023 Sep 21.]Na Qu, Yiming Meng, Jingbo Zhai, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Gastroenterology & Hepatology|October 1, 2011
The cantankerous pancreasR Thomas Temes, Noreen Griffin
International Immunopharmacology|June 10, 2018
Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapyZijian Li, Yue You, Noreen Griffin, et al.
International Immunopharmacology|March 2, 2016
Methionine enkephalin, its role in immunoregulation and cancer therapyDingliang Zhao, Nicolas Plotnikoff, Noreen Griffin, et al.
International Immunopharmacology|July 27, 2021
A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironmentShuling Zhang, Hai Huang, Mike Handley, et al.
International Immunopharmacology|January 24, 2014
Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs)Jingjuan Meng, Yiming Meng, Nicholas P Plotnikoff, et al.
International Immunopharmacology|December 14, 2019
Methionine enkephalin inhibits influenza A virus infection through upregulating antiviral state in RAW264.7 cellsJing Tian, Na Qu, Xue Jiao, et al.
International Immunopharmacology|September 23, 2023
Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b<sup>+</sup> NCR1<sup>+</sup> NKs of tumor microenvironmentNa Qu, Yiming Meng, Jingbo Zhai, et al.
International Immunopharmacology|August 27, 2016
Functional modulation on macrophage by low dose naltrexone (LDN)Zhe Yi, Shengnan Guo, Xu Hu, et al.
International Immunopharmacology|November 17, 2023
In vitro and in vivo killing effects of methionine enkephalin on osteosarcomaHai Huang, Xiaonan Wang, Shuling Zhang, et al.
International Immunopharmacology|July 28, 2024
Corrigendum to "Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b+ NCR1+ NKs of tumor microenvironment" [Int. Immunopharmacol. 124(Pt B) (2023) 110967. doi: 10.1016/j.intimp.2023.110967. Epub 2023 Sep 21.]Na Qu, Yiming Meng, Jingbo Zhai, et al.
Pageof 3